Revista de Medicina Desportiva (English) March 2018 | Page 24

that mesotherapy, when associated
with other therapeutic techniques,
for instance TENS (Transcutaneous
Electric Nerve Stimulation), has faster
good results in reducing pain than
when they are applied in isolation,
which is similar to the results dem-
onstrated in other papers, where
mesotherapy was associated with
other therapeutic techniques, such
as TENS and laser or dynamic thera-
pies. 14.15
On the beginning of this decade,
on a meeting where several medi-
cal specialties were present, it was
reviewed and validated the rational
use, indications, advantages and
contraindications of mesotherapy
with the purpose to create a series
of recommendations of the appro-
priate use of Intradermal therapy.
It was concluded that intradermal
administration is effective to fight
pain and it should be considered
another therapeutic “weapon” that
doctors can use. 16 In the case of the
persistence of pain implies a new
clinical evaluation and therapeutic
decision. 3
Currently, in France, mesotherapy
is recognized by the French Medical
Academy as a legitimate technique
to control pain, its costs are reim-
bursed by Social security and it is
applied in most sports and in medi-
cal centers as well. 17
References
1. Baranowski A, Buffington T, Collett B, et al.
Classification of Chronic Pain, Second Edition
(Revised). Pain. 2011.
2. Treede RD, Rief W, Barke A, A classification of
chronic pain for ICD-11. Pain. 2015; 156:1003-7.
3. Mammucari M, Gatti A, Maggiori S, et al.
Role of Mesotherapy in Musculoskeletal Pain:
Opinions from the Italian Society of Mesothe-
rapy. Evidence-Based Complementary and
Alternative Medicine. 2012; 2012:1-12.
4. Mason L, Moore RA, Edwards JE, et al. Topi-
cal NSAIDs for chronic musculoskeletal pain:
systematic review and meta-analysis. BMC
Musculoskelet Disord. 2004; 19:5-28.
5. Sivagnanam G.Mesotherapy – The french
connection. J Pharmacol Pharmacother. 2010;
1:4-8.
6. Mendonça R, Ramires I. Mesoterapia (2016).
Lisboa: 1.ª edição, Lidel.
7. Gancedo HE. Cap 1: Generalidades da Meso-
terapia. In Tratado deMesoterapia. El Fenix,
2008.
8. Herreros FOC, Moraes AM, Velho PENF.
Mesotherapy: a bibliographical review.
Anais Brasileiros de Dermatologia, 2011;
86(1):96–101.
9. Binaglia L, Marconi P and Pitzurra M.
Absorption of Na ketoprofen administered
intradermally. Giornale di Mesoterapia; 1981;
1:85–91.
10. Hsu CC, Kuo HC, Hsu CT, et al. Abdominal
mesotherapy injection extended the absorption
of follicle-stimulating hormone. Fertility and
Sterility, 2011; 95(6):2134–2136.
11. Herreros F, Aparecida M, et al.Mesotherapy:
a bibliographical review. An. Bras. Dermatol.
2011; 86(1):96-101.
12. Coz J. Traité de mésothérapie (2009). Paris: 2.º
edition, Masson.
Mesoterapia teatment algorithm
History and clinical evaluation
Mesoterapia with AINEs and Myelogenous drugs
NPRS 1-4
NPRS 5-7
NPRS 8-10
NPRS
reduction of
70% NPRS
reduction of
> 70% NPRS
reduction of
< 50% NPRS
reduction of
> 70% NPRS
reduction of
< 50%
Weekly
sessions for
4 weeks Weekly
sessions for
4 weeks Weekly
sessions
until
reduction of
NPRS by 50% Weekly
sessions
until
reduction of
NPRS by 50% Sessions
every 3
days until
reduction of
NPRS by 50%
Fortnightly
sessions as
needed Fortnightly
sessions
until
reduction of
NPRS > 70% Fortnightly
sessions as
needed Weekly
sessions
until
reduction of
NPRS > 50% Weekly
sessions
until
reduction of
NPRS > 50%
Monthly sessions as needed
Fortnightly sessions as needed
Algorithm adapted for the use of NSAIDs and myorelaxants on mesotherapy for the
muscle-skeletal pain 3
22 march 2018 www.revdesportiva.pt
13. Cereser C, Ganzit GP, and Gribaudo C.
Injuries affecting the locomotory system during
the game of rugby. Reports of 133 cases treated
with mesotherapy. Giornale di Mesoterapia.
1985; (5):9-19.
14. Palermo S, Riello R, Cammardella MP et al.
TENS+ mesotherapy association in the therapy
of cervico-brachialgia: preliminary data.
Minerva Anestesiologica. 1991; 57(10):1084-
1085.
15. Solinas G, Solinas AL, Perra P, and Solinas
FL. Treatment of mechanical tendinopathies
by mesotherapy with orgotein in combination
with laser therapy. Riabilitazione, 1987;
20(4):281–288.
16. Mammucari M, Gatti A, Maggiori
S,Bartoletti CA, and Sabato AF. Mesothe-
rapy, definition, rationale and clinical role: a
consensus report from the Italian Society of
Mesotherapy. European Review for Medical
and Pharmacological Science, 2011;
15(6):682-69.
17. Laurens, D. Suivitraumatologique des perchis-
tes de l’INSEP de juillet 1998 a juillet 2000,
presented at the 9 th International mesotherapy
meeting of the French Society of Mesotherapy,
Paris, October 20-22nd, 2000, pp145-162 of
the conference manual.